-
1
-
-
0028049247
-
The adjuvant effect of interleukin-12 in a vaccine against Leishmania major
-
Afonso, L. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235-237.
-
(1994)
Science
, vol.263
, pp. 235-237
-
-
Afonso, L.C.1
Scharton, T.M.2
Vieira, L.Q.3
Wysocka, M.4
Trinchieri, G.5
Scott, P.6
-
2
-
-
0038176089
-
Montanide ISA 720 and 51: A new generation of water in oil emulsions as adjuvants for human vaccines
-
Aucouturier J., L. Dupuis, S. Deville, S. Ascarateil, and V. Ganne. 2002. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines. Expert Rev. Vaccines 1:111-118.
-
(2002)
Expert Rev. Vaccines
, vol.1
, pp. 111-118
-
-
Aucouturier, J.1
Dupuis, L.2
Deville, S.3
Ascarateil, S.4
Ganne, V.5
-
3
-
-
0037205207
-
Aluminum salts in vaccines-US perspective
-
Baylor, N. W., W. Egan, and P. Richman. 2002. Aluminum salts in vaccines-US perspective, Vaccine 20:818-23.
-
(2002)
Vaccine
, vol.20
, pp. 818-823
-
-
Baylor, N.W.1
Egan, W.2
Richman, P.3
-
4
-
-
0035914841
-
The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure
-
Belkaid, Y., K. F. Hoffmann, S. Mendez, S. Kamhawi, M. C. Udey, T. A. Wynn, and D. L. Sacks. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194:1497-1506.
-
(2001)
J. Exp. Med.
, vol.194
, pp. 1497-1506
-
-
Belkaid, Y.1
Hoffmann, K.F.2
Mendez, S.3
Kamhawi, S.4
Udey, M.C.5
Wynn, T.A.6
Sacks, D.L.7
-
5
-
-
2242423605
-
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
-
Belkaid, Y., C. A. Piccirillo, S. Mendez, E. M. Shevach, and D. L. Sacks. 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420:502-507.
-
(2002)
Nature
, vol.420
, pp. 502-507
-
-
Belkaid, Y.1
Piccirillo, C.A.2
Mendez, S.3
Shevach, E.M.4
Sacks, D.L.5
-
6
-
-
0142026114
-
Vaccines in leishmaniasis: Advances in the last five years
-
Brodskyn, C., de Oliviera, C., Barral, A., Barral-Netto, M. 2003. Vaccines in leishmaniasis: Advances in the last five years. Expert Rev. Vaccines 2:705-717.
-
(2003)
Expert Rev. Vaccines
, vol.2
, pp. 705-717
-
-
Brodskyn, C.1
De Oliviera, C.2
Barral, A.3
Barral-Netto, M.4
-
7
-
-
0036073291
-
Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducibie protein 1, and Leishmania elongation initiation factor protects against leishmaniasis
-
Coler, R. N., Y. A. W. Skeiky, K. Bernards, K. Greeson, D. Carter, C. D. Cornellison, F. Modabber, A. Campos-Neto, and S. G. Reed. 2002. Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducibie protein 1, and Leishmania elongation initiation factor protects against leishmaniasis. Infect. Immun. 70:4215-4225.
-
(2002)
Infect. Immun.
, vol.70
, pp. 4215-4225
-
-
Coler, R.N.1
Skeiky, Y.A.W.2
Bernards, K.3
Greeson, K.4
Carter, D.5
Cornellison, C.D.6
Modabber, F.7
Campos-Neto, A.8
Reed, S.G.9
-
8
-
-
0035067363
-
Leishmaniasis: Current status of vaccine development
-
Handman, E. 2001. Leishmaniasis: current status of vaccine development, Clin. Microbiol. Rev. 14:229-243.
-
(2001)
Clin. Microbiol. Rev.
, vol.14
, pp. 229-243
-
-
Handman, E.1
-
9
-
-
0025768733
-
Production of interferon-gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis
-
Heinzel, F. P., M. D. Sadick, S. S. Mutha, and R. M. Locksley. 1991. Production of interferon-gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88:7011-7015.
-
(1991)
Proc. Natl. Acad. Sci. USA
, vol.88
, pp. 7011-7015
-
-
Heinzel, F.P.1
Sadick, M.D.2
Mutha, S.S.3
Locksley, R.M.4
-
10
-
-
0024540908
-
Reciprocal expression of interferon-gamma or interleukin-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets
-
Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon-gamma or interleukin-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59-72.
-
(1989)
J. Exp. Med.
, vol.169
, pp. 59-72
-
-
Heinzel, F.P.1
Sadick, M.D.2
Holaday, B.J.3
Coffman, R.L.4
Locksley, R.M.5
-
11
-
-
0027336689
-
Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages
-
Hsieh, C. S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy. 1993. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
-
(1993)
Science
, vol.260
, pp. 547-549
-
-
Hsieh, C.S.1
Macatonia, S.E.2
Tripp, C.S.3
Wolf, S.F.4
O'Garra, A.5
Murphy, K.M.6
-
12
-
-
0031225598
-
Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1-cytokine responses to HIV-1 gp120
-
Jankovic, D., P. Caspar, M. Zweig, M. Garcia-Moll, S. D. Showalter, F. R. Vogel, and A. Sher. 1997. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1-cytokine responses to HIV-1 gp120. J. Immunol. 159:2409-2417.
-
(1997)
J. Immunol.
, vol.159
, pp. 2409-2417
-
-
Jankovic, D.1
Caspar, P.2
Zweig, M.3
Garcia-Moll, M.4
Showalter, S.D.5
Vogel, F.R.6
Sher, A.7
-
13
-
-
0032864099
-
Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis
-
Kennet, R. T., D. L. Sacks, J. P. Sypek, L. Vilela, A. A. Gam, and K. Evans-Davis. 1999. Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. J. Immunol. 163:4481-4488.
-
(1999)
J. Immunol.
, vol.163
, pp. 4481-4488
-
-
Kennet, R.T.1
Sacks, D.L.2
Sypek, J.P.3
Vilela, L.4
Gam, A.A.5
Evans-Davis, K.6
-
14
-
-
0031081560
-
A simple method for quantifying Leishmania in tissues of infected animals
-
Lima, H. C., J. Bleyenberg, and R. G. Titus. 1997. A simple method for quantifying Leishmania in tissues of infected animals. Parasitol. Today 13:80-82.
-
(1997)
Parasitol. Today
, vol.13
, pp. 80-82
-
-
Lima, H.C.1
Bleyenberg, J.2
Titus, R.G.3
-
15
-
-
0031880178
-
A diagnostic ELISA for visceral leishmaniasis, based on antigen from media conditioned by Leishmania donovani promastigotes
-
Martin, S. K., L. Thuita-Harun, M. Adoyo-Adoyo, and K. M. Wasunna. 1998. A diagnostic ELISA for visceral leishmaniasis, based on antigen from media conditioned by Leishmania donovani promastigotes. Ann. Trop. Med. Parasitol. 92:571-577.
-
(1998)
Ann. Trop. Med. Parasitol.
, vol.92
, pp. 571-577
-
-
Martin, S.K.1
Thuita-Harun, L.2
Adoyo-Adoyo, M.3
Wasunna, K.M.4
-
16
-
-
0020060136
-
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P 815.III. Clonal analysis of the syngeneic cytolytic T lymphocyte response
-
Maryanski, J., J. van Snick, J. C. Cerrotini, and T. Boon. 1982. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P 815.III. Clonal analysis of the syngeneic cytolytic T lymphocyte response. Eur. J. Immunol. 12:401-406.
-
(1982)
Eur. J. Immunol.
, vol.12
, pp. 401-406
-
-
Maryanski, J.1
Van Snick, J.2
Cerrotini, J.C.3
Boon, T.4
-
17
-
-
0034141850
-
IL-13 is a susceptibility factor for Leishmania major infection
-
Matthews, D. J., C. L. Emson, G. J. McKenzie, H. E. Jolin, J. M. Blackwell, and A. N. McKenzie. 2000. IL-13 is a susceptibility factor for Leishmania major infection. J. Immunol. 164:1458-1462.
-
(2000)
J. Immunol.
, vol.164
, pp. 1458-1462
-
-
Matthews, D.J.1
Emson, C.L.2
McKenzie, G.J.3
Jolin, H.E.4
Blackwell, J.M.5
McKenzie, A.N.6
-
18
-
-
0036035705
-
Vaccination against cutaneous leishmaniasis, Current status
-
Melby, P. C. 2002. Vaccination against cutaneous leishmaniasis. Current status. Am. J. Clin. Dermatol. 3:557-570.
-
(2002)
Am. J. Clin. Dermatol.
, vol.3
, pp. 557-570
-
-
Melby, P.C.1
-
19
-
-
0028376372
-
Does lipophosphoglycan enhance the T cell-stimulatory activity of lipophosphoglycan-associated proteins?
-
Mendonca, S. C., P. M. De-Luca, R. W. Olafson, A. Jardim, and S. G. Coutinho. 1994. Does lipophosphoglycan enhance the T cell-stimulatory activity of lipophosphoglycan-associated proteins? Braz. J. Med. Biol. Res. 27:553-557.
-
(1994)
Braz. J. Med. Biol. Res.
, vol.27
, pp. 553-557
-
-
Mendonca, S.C.1
De-Luca, P.M.2
Olafson, R.W.3
Jardim, A.4
Coutinho, S.G.5
-
20
-
-
0028207191
-
Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection
-
Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Gause, B. R. Hubbard, M. K. Gately, and F. D. Finkelman. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1047-1056.
-
(1994)
J. Immunol.
, vol.152
, pp. 1047-1056
-
-
Morris, S.C.1
Madden, K.B.2
Adamovicz, J.J.3
Gause, W.C.4
Hubbard, B.R.5
Gately, M.K.6
Finkelman, F.D.7
-
21
-
-
0038560975
-
The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major
-
Noben-Trauth, N., R. Lira, H. Nagase, W. E. Paul, and D. L. Sacks. 2003. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. J. Immunol. 170:5152-5158.
-
(2003)
J. Immunol.
, vol.170
, pp. 5152-5158
-
-
Noben-Trauth, N.1
Lira, R.2
Nagase, H.3
Paul, W.E.4
Sacks, D.L.5
-
22
-
-
0035898935
-
Paradoxical effects of IL-12 in leishmaniasis in the presence and absence of vaccinating antigen
-
Noormohammadi, A. H., H. Hochrein, J. M. Curtis, T. M. Baldwin, and E. Handman. 2001. Paradoxical effects of IL-12 in leishmaniasis in the presence and absence of vaccinating antigen. Vaccine 19:4043-4052.
-
(2001)
Vaccine
, vol.19
, pp. 4043-4052
-
-
Noormohammadi, A.H.1
Hochrein, H.2
Curtis, J.M.3
Baldwin, T.M.4
Handman, E.5
-
23
-
-
0042405127
-
Vaccines for parasitic and bacterial diseases
-
Reed, S. G., and Campos-Neto, A. 2003. Vaccines for parasitic and bacterial diseases. Curr. Opin. Immunol. 15:456-460.
-
(2003)
Curr. Opin. Immunol.
, vol.15
, pp. 456-460
-
-
Reed, S.G.1
Campos-Neto, A.2
-
24
-
-
0002988779
-
Immunologic mechanisms in Leishmania
-
M. W. Cunningham and R. S. Fujinami (ed.). Lippincott, Williams & Wilkins, Philadelphia, Pa.
-
Reed, S. G., and P. Scott. 2000. Immunologic mechanisms in Leishmania, p. 537-554, In M. W. Cunningham and R. S. Fujinami (ed.), Effects of microbes on the immune system. Lippincott, Williams & Wilkins, Philadelphia, Pa.
-
(2000)
Effects of Microbes on the Immune System
, pp. 537-554
-
-
Reed, S.G.1
Scott, P.2
-
25
-
-
0036197939
-
Enzyme-linked immunosorbent assay based on soluble promastigote antigen detects immunoglobulin M (IgM) and IgG antibodies in sera from cases of visceral and cutaneous leishmaniasis
-
Ryan, J. R., A M. Smithyman, G. H. Rajasekariah, L. Hochberg, J. M. Stiteler, and S. K. Martin. 2002. Enzyme-linked immunosorbent assay based on soluble promastigote antigen detects immunoglobulin M (IgM) and IgG antibodies in sera from cases of visceral and cutaneous leishmaniasis. J. Clin. Microbiol. 40:1037-1043.
-
(2002)
J. Clin. Microbiol.
, vol.40
, pp. 1037-1043
-
-
Ryan, J.R.1
Smithyman, A.M.2
Rajasekariah, G.H.3
Hochberg, L.4
Stiteler, J.M.5
Martin, S.K.6
-
26
-
-
0021320759
-
Identification of an infective stage of Leishmania promastigotes
-
Sacks, D. L., and P. V. Perkins. 1984, Identification of an infective stage of Leishmania promastigotes. Science 223:1417-1419.
-
(1984)
Science
, vol.223
, pp. 1417-1419
-
-
Sacks, D.L.1
Perkins, P.V.2
-
27
-
-
0028842832
-
Development of a safe live Leishmania vaccine line by gene replacement
-
Titus, R., F. Gueiros-Filho, L. A. de Freitas, and S. M. Beverley. 1995. Development of a safe live Leishmania vaccine line by gene replacement, Proc. Natl. Acad. Sci. USA 92:10267-10271.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 10267-10271
-
-
Titus, R.1
Gueiros-Filho, F.2
De Freitas, L.A.3
Beverley, S.M.4
-
28
-
-
0028128138
-
Interactions between Leishmania major and macrophages
-
Titus, R. G., C. M. Theodos, A. Shankar, and L. R. Hall. 1994. Interactions between Leishmania major and macrophages. Immunol. Ser. 60:437-459.
-
(1994)
Immunol. Ser.
, vol.60
, pp. 437-459
-
-
Titus, R.G.1
Theodos, C.M.2
Shankar, A.3
Hall, L.R.4
-
29
-
-
0027027503
-
Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation
-
Trinchieri, G., M. Wysocka, A. D'Andrea, M. Rengaraju, M. Aste-Amezaga, M. Kubin, N. M. Valiante, and J. Chehimi. 1992. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog. Growth Factor Res. 4:355-368.
-
(1992)
Prog. Growth Factor Res.
, vol.4
, pp. 355-368
-
-
Trinchieri, G.1
Wysocka, M.2
D'Andrea, A.3
Rengaraju, M.4
Aste-Amezaga, M.5
Kubin, M.6
Valiante, N.M.7
Chehimi, J.8
-
30
-
-
0031842834
-
Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family
-
Webb, J. R., A. Campos-Neto, P. J. Ovendale, T. I. Martin, E. J. Stromberg, R. Badaro, and S. G. Reed. 1998. Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family. Infect. Immun. 66:3279-3289.
-
(1998)
Infect. Immun.
, vol.66
, pp. 3279-3289
-
-
Webb, J.R.1
Campos-Neto, A.2
Ovendale, P.J.3
Martin, T.I.4
Stromberg, E.J.5
Badaro, R.6
Reed, S.G.7
|